Open Nav

Sindolor LLC

  • Jon Newland, Sindolor LLC

Generate interest for Series A funding

  • Date:Wednesday, October 17
  • Time:10:00 AM - 10:15 AM
  • Room:Olympic
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Sindolor LLC has developed an opioid replacement and narcotic dependency treatment medicine, utilizing cannabis extract as one ingredient. The medicine is non-toxic, benign as far as side effects, economical to manufacture, and deliverable orally and by the other usual means of administration. Results from our initial exploratory Phase I non-FDA medical trial show outstanding promise, exceeding all expectations. It can replace opioids, even morphine, for pain management - with none of the dangers associated with opiates. Sindolor LLC has in development an additional four unique formulations addressing other therapeutic indications , several of which are ready for provisional patent filing.
  • Company Website:sindolor.org
  • Company HQ City:Palm Desert
  • Company HQ Country:United States
  • Company HQ State:California                  
  • CEO/Top Company Official:Jon Newland
  • Year Founded:2017
  • Main Therapeutic Focus:Pain Management
  • Lead Product in Development :An opioid dependency and pain management treatment
  • Development Phase of Primary Product:Phase I
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :six
  • Additional Information/Comments:Other team members: Dr. Krishan Kumar has over 25 years of big pharma R&D experience. He is a medical college professor and molecular imaging expert. He owns and operates a private formulation lab as well as a pharmaceutical consultancy. Dr. Timothy Newland is a board certified Oral and Maxillofacial Surgeon, who has practiced the full scope of his profession for 38 years. His expertise includes dentoalveolar surgery, trauma, congenital defects, pathology, and facial reconstruction. He is expert in pain management. The Sindolor patent attorney is a former industrial organic chemist and has 13 of his own patents.
  • Previous and Current Investors:Founders self-funded
  • Size of Last Investment Round:75000
  • Total Amount Raised to Date, In All Rounds:75000
Speakers
Jon Newland
Sindolor LLC
Back